Dendritic Cell Vaccination for Patients with Solid Tumors

NCT01291420 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Renal Cell Carcinoma
Sarcomas
Breast Cancers
Malignant Mesothelioma
Colorectal Tumors

Interventions

BIOLOGICAL: autologous dendritic cell vaccination

Sponsor

University Hospital, Antwerp